
Medtronic PLC Stock Underperforms Thursday When Compared To Competitors

I'm PortAI, I can summarize articles.
Medtronic PLC's stock fell 1.01% to $99.75 on Thursday, underperforming compared to competitors like Johnson & Johnson, Danaher Corp., and Abbott Laboratories, which saw gains. Despite a favorable trading session for the market, Medtronic's stock remains 6.19% below its 52-week high. Trading volume was slightly below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

